TRVI Institutional Ownership

TREVI THERAPEUTICS INC

Latest close $18.50 as of Aug 5, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Aug 6, 2026
Public consensus preview Accumulation leaning 70/100 institutional research score
3 tracked institutions Latest filing Aug 6, 2026

1 accumulating across 1 comparable institution.

Accumulating1
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$5.47 52-week high$19.26
Latest close $18.50 94.5% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
Fidelity / FMR Aug 6, 2026 filed
Vanguard Group Mar 27, 2026 filed
BlackRock Oct 17, 2025 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 6 parsed filing(s) · 3 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
Fidelity / FMR CIK0000315066 Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment Reported accumulation 12.6K +4.5K 8.80% -3.20 pts $18.65 $18.24 $18.50
Fidelity / FMR CIK0000315066 Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment Reported accumulation 8.0K +1.5K 12.00% 0.00 pts $11.93 $14.26 $18.50
Vanguard Group CIK0000102909 Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment Earliest Schedule 13G amendment found 11 12.00% $11.01 $11.33 $18.50
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

VOR VOR BIOPHARMA INC 70/100 Accumulation leaning ZVRA ZEVRA THERAPEUTICS, INC. 70/100 Accumulation leaning SPCE VIRGIN GALACTIC HOLDINGS INC 70/100 Accumulation leaning SUNB SUNBELT RENTALS HOLDINGS INC 70/100 Accumulation leaning

Recent multi-institution accumulation

TVTX TRAVERE THERAPEUTICS INC 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026